Jia; Lanqi
Patent Applications and Registrations
Patent applications and USPTO patent grants for Jia; Lanqi.The latest application filed is for "dihydropyrrolopyridine inhibitors of ror-gamma".
Company Profile
14.34.44
- Jia; Lanqi - Horsham PA
- Jia; Lanqi - Horshman PA
- Jia; Lanqi - Ambler PA
Patent Activity
| Patent | Date |
|---|---|
| Dihydropyrrolopyridine Inhibitors Of Ror-gamma App 20210238174 - Claremon; David A. ; et al. | 2021-08-05 |
| Inhibitors Of The Menin-mll Interaction App 20210179611 - CACATIAN; Salvacion ; et al. | 2021-06-17 |
| Modulators of ROR-gamma Grant 11,008,340 - Claremon , et al. May 18, 2 | 2021-05-18 |
| Inhibitors Of The Menin-mll Interaction App 20210053974 - CACATIAN; Salvacion ; et al. | 2021-02-25 |
| Inhibitors of the menin-MLL interaction Grant 10,899,758 - Cacatian , et al. January 26, 2 | 2021-01-26 |
| Dihydropyrrolopyridine Inhibitors Of Ror-gamma App 20200339566 - Claremon; David A. ; et al. | 2020-10-29 |
| Dihydropyrrolopyridine inhibitors of ROR-gamma Grant 10,807,980 - Claremon , et al. October 20, 2 | 2020-10-20 |
| Inhibitors of the menin-MLL interaction Grant 10,683,302 - Cacatian , et al. | 2020-06-16 |
| Dihydropyrrolopyridine Inhibitors Of Ror-gamma App 20200172535 - Claremon; David A. ; et al. | 2020-06-04 |
| Purine derivatives as CD73 inhibitors for the treatment of cancer Grant 10,654,884 - Cacatian , et al. | 2020-05-19 |
| Modulators Of Ror-gamma App 20190322687 - Claremon; David A. ; et al. | 2019-10-24 |
| Dihydropyrrolopyridine inhibitors of ROR-gamma Grant 10,399,976 - Claremon , et al. Sep | 2019-09-03 |
| Inhibitors Of The Menin-mll Interaction App 20190202830 - CACATIAN; Salvacion ; et al. | 2019-07-04 |
| Inhibitors of beta-secretase Grant 10,336,717 - Cacatian , et al. | 2019-07-02 |
| Inhibitors Of The Menin-mll Interaction App 20190144459 - Cacatian; Salvacion ; et al. | 2019-05-16 |
| Inhibitors Of The Menin-mll Interaction App 20190010167 - Claremon; David A. ; et al. | 2019-01-10 |
| Dihydropyrrolopyridine Inhibitors Of Ror-gamma App 20180370968 - Claremon; David A. ; et al. | 2018-12-27 |
| Inhibitors Of Beta-secretase App 20180344734 - Bukhtiyarov; Yuri ; et al. | 2018-12-06 |
| Dihydropyrrolopyridine inhibitors of ROR.gamma. Grant 10,087,184 - Claremon , et al. October 2, 2 | 2018-10-02 |
| Dihydropyrrolopyridine inhibitors of ROR-gamma Grant 10,047,085 - Claremon , et al. August 14, 2 | 2018-08-14 |
| Dihydropyrrolopyridine Inhibitors Of Ror-gamma App 20180222902 - Claremon; David A. ; et al. | 2018-08-09 |
| Inhibitors of beta-secretase Grant 9,949,975 - Bukhtiyarov , et al. April 24, 2 | 2018-04-24 |
| Thiazolopyrrolidine inhibitors of ROR- .gamma. Grant 9,868,748 - Claremon , et al. January 16, 2 | 2018-01-16 |
| Isoindoline inhibitors of ROR-gamma Grant 9,845,308 - Claremon , et al. December 19, 2 | 2017-12-19 |
| Dihydropyrrolopyridine inhibitors of ROR-gamma Grant 9,796,710 - Claremon , et al. October 24, 2 | 2017-10-24 |
| Dihydropyrrolopyridine Inhibitors Of Ror-gamma App 20170260180 - Claremon; David A. ; et al. | 2017-09-14 |
| Inhibitors Of Beta-secretase App 20170196867 - Bukhtiyarov; Yuri ; et al. | 2017-07-13 |
| Dihydropyrrolopyridine inhibitors of ROR-gamma Grant 9,624,217 - Claremon , et al. April 18, 2 | 2017-04-18 |
| Dihydropyrrolopyridine Inhibitors Of Ror-gamma App 20170081327 - Claremon; David A. ; et al. | 2017-03-23 |
| Purine Derivatives As Cd73 Inhibitors For The Treatment Of Cancer App 20170044203 - Cacatian; Salvacion ; et al. | 2017-02-16 |
| Thiazolopyrrolidine Inhibitors Of Ror-gamma App 20170008910 - Claremon; David A. ; et al. | 2017-01-12 |
| Inhibitors of beta-secretase Grant 9,526,727 - Bukhtiyarov , et al. December 27, 2 | 2016-12-27 |
| Inhibitors Of Beta-secretase App 20160272600 - Cacatian; Salvacion ; et al. | 2016-09-22 |
| Dihydropyrrolopyridine Inhibitors Of Ror-gamma App 20160200724 - Claremon; David A. ; et al. | 2016-07-14 |
| Isoindoline Inhibitors Of Ror-gamma App 20160122318 - Claremon; David A. ; et al. | 2016-05-05 |
| Inhibitors of beta-secretase Grant 9,212,153 - Cacatian , et al. December 15, 2 | 2015-12-15 |
| Inhibitors Of Beta-secretase App 20150239849 - Bukhtiyarov; Yuri ; et al. | 2015-08-27 |
| Dihydropyrrolopyridine Inhibitors Of Ror-gamma App 20150218160 - Claremon; David A. ; et al. | 2015-08-06 |
| Inhibitors Of Beta-secretase App 20150150872 - Bukhtiyarov; Yuri ; et al. | 2015-06-04 |
| Inhibitors of beta-secretase Grant 9,045,500 - Dillard , et al. June 2, 2 | 2015-06-02 |
| Inhibitors of beta-secretase Grant 9,018,391 - Bukhtiyarov , et al. April 28, 2 | 2015-04-28 |
| Inhibitors of .beta.-secretase Grant 8,981,112 - Bukhtiyarov , et al. March 17, 2 | 2015-03-17 |
| Inhibitors Of Beta-secretase App 20150031691 - Dillard; Lawrence Wayne ; et al. | 2015-01-29 |
| Inhibitors of beta-secretase Grant 8,921,359 - Dillard , et al. December 30, 2 | 2014-12-30 |
| Inhibitors of beta-secretase Grant 8,889,703 - Dillard , et al. November 18, 2 | 2014-11-18 |
| Inhibitors Of Beta-secretase App 20140200223 - Cacatian; Salvacion ; et al. | 2014-07-17 |
| Inhibitors Of Beta-secretase App 20140057927 - Bukhtiyarov; Yuri ; et al. | 2014-02-27 |
| Inhibitors of beta-secretase Grant 8,633,212 - Cacatian , et al. January 21, 2 | 2014-01-21 |
| Inhibitors Of Beta-secretase App 20130317014 - Dillard; Lawrence W. ; et al. | 2013-11-28 |
| Piperidine renin inhibitors Grant 8,580,823 - Baldwin , et al. November 12, 2 | 2013-11-12 |
| Inhibitors Of Beta-secretase App 20130289050 - Bukhtiyarov; Yuri ; et al. | 2013-10-31 |
| Salts Of Methyl 2-((R)-(3-Chlorophenyl)((R)-1-((S)-2-(Methylamino)-3-((R)-Tetrahydro-2H-P- yran-3-Yl)Propylcarbamoyl)Piperidin-3-Yl)Methoxy)Ethylcarbamate App 20130197034 - Claremon; David A. ; et al. | 2013-08-01 |
| Inhibitors of beta-secretase Grant 8,450,308 - Dillard , et al. May 28, 2 | 2013-05-28 |
| Inhibitors Of Beta-secretase App 20130053377 - Dillard; Lawrence W. ; et al. | 2013-02-28 |
| Salts of methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-p- yran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate Grant 8,372,978 - Claremon , et al. February 12, 2 | 2013-02-12 |
| Piperidine Renin Inhibitors App 20120225906 - Baldwin; John J. ; et al. | 2012-09-06 |
| Piperidine renin inhibitors Grant 8,198,453 - Baldwin , et al. June 12, 2 | 2012-06-12 |
| Renin inhibitors Grant 8,106,221 - Baldwin , et al. January 31, 2 | 2012-01-31 |
| Inhibitors Of Beta-Secretase App 20110218192 - Dillard; Lawrence W. ; et al. | 2011-09-08 |
| Salts Of Methyl 2-((r)-(3-chlorophenyl)((r)-1-((s)-2-(methylamino)-3-((r)-tetrahydro-2h-p- Yran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate App 20110098321 - Claremon; David A. ; et al. | 2011-04-28 |
| Inhibitors Of Beta-secretase App 20110071126 - CACATIAN; Salvacion ; et al. | 2011-03-24 |
| Renin Inhibitors App 20100190829 - Baldwin; John J. ; et al. | 2010-07-29 |
| Renin Inhibitors App 20100184805 - Baldwin; John J. ; et al. | 2010-07-22 |
| Renin Inhibitors App 20100168243 - Baldwin; John J. ; et al. | 2010-07-01 |
| Renin Inhibitors App 20100144825 - Baldwin; John J. ; et al. | 2010-06-10 |
| Renin Inhibitors App 20090312369 - Baldwin; John J. ; et al. | 2009-12-17 |
| Novel Process for the Preparation of Nonracemic Long Chain alpha-Amino Acid Derivatives App 20090036708 - Jia; Lanqi ; et al. | 2009-02-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 